Percutaneous coronary intervention: Historical perspectives, current status, and future directions

被引:36
作者
Arjomand, H [1 ]
Turi, ZG [1 ]
McCormick, D [1 ]
Goldberg, S [1 ]
机构
[1] Drexel Univ, Coll Med, Dept Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S0002-8703(03)00153-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the twenty-six years since Gruntzig introduced a simple balloon angioplasty technique, percutaneous coronary intervention has undergone extraordinary growth and has now surpassed bypass surgery in frequency of performance. Several critical breakthrough technologies account for this remarkable progress: intracoronary stents have increased success rates and reduced restenosis, adjunctive antiplatelet therapy has reduced periprocedural complications, and restenosis after stent placement has been effectively treated with local radiation. Most recently, drug-eluting stents coated with cell-cycle inhibitors have shown great promise for further reducing restenosis, possibly to negligible levels.
引用
收藏
页码:787 / 796
页数:10
相关论文
共 99 条
[1]   Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients - Insights from the Arterial Revascularization Therapy Study (ARTS) trial [J].
Abizaid, A ;
Costa, MA ;
Centemero, M ;
Abizaid, AS ;
Legrand, VMG ;
Limet, RV ;
Schuler, G ;
Mohr, FW ;
Lindeboom, W ;
Sousa, AGMR ;
Sousa, JE ;
van Hout, B ;
Hugenholtz, PG ;
Unger, F ;
Serruys, PW .
CIRCULATION, 2001, 104 (05) :533-538
[2]  
Ajani A E, 2001, J Invasive Cardiol, V13, P554
[3]   Coronary artery stents [J].
Al Suwaidi, J ;
Berger, PB ;
Holmes, DR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (14) :1828-1836
[4]  
Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122
[5]  
Arjomand H, 2003, J AM COLL CARDIOL, V41, p23A
[6]   RESULTS OF DIRECTIONAL CORONARY ATHERECTOMY DURING MULTICENTER PREAPPROVAL TESTING [J].
BAIM, DS ;
HINOHARA, T ;
HOLMES, D ;
TOPOL, E ;
PINKERTON, C ;
KING, SB ;
WHITLOW, P ;
KEREIAKES, D ;
FARLEY, B ;
SIMPSON, JB .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (13) :E6-E11
[7]   Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts [J].
Baim, DS ;
Wahr, D ;
George, B ;
Leon, MB ;
Greenberg, J ;
Cutlip, DE ;
Kaya, U ;
Popma, JJ ;
Ho, KKL ;
Kuntz, RE .
CIRCULATION, 2002, 105 (11) :1285-1290
[8]   Treatment of aortocoronary vein graft lesions with membrane-covered stents -: A multicenter surveillance trial [J].
Baldus, S ;
Köster, R ;
Elsner, M ;
Walter, DH ;
Arnold, R ;
Auch-Schwelk, W ;
Berger, J ;
Rau, M ;
Meinertz, T ;
Zeiher, AM ;
Hamm, CW .
CIRCULATION, 2000, 102 (17) :2024-2027
[9]   Clinical implications of percutaneous coronary intervention-Clopidogrel in unstable angina to prevent Recurrent Events (PCI-CURE) study - A US perspective [J].
Berger, PB ;
Steinhubl, S .
CIRCULATION, 2002, 106 (17) :2284-2287
[10]   Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) [J].
Bertrand, ME ;
Rupprecht, HJ ;
Urban, P ;
Gershlick, AH .
CIRCULATION, 2000, 102 (06) :624-629